NANO-X IMAGING LTD (NNOX) Fundamental Analysis & Valuation
NASDAQ:NNOX • IL0011681371
Current stock price
2.27 USD
-0.02 (-0.87%)
At close:
2.28 USD
+0.01 (+0.44%)
After Hours:
This NNOX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. NNOX Profitability Analysis
1.1 Basic Checks
- In the past year NNOX has reported negative net income.
- In the past year NNOX has reported a negative cash flow from operations.
- NNOX had negative earnings in each of the past 5 years.
- In the past 5 years NNOX always reported negative operating cash flow.
1.2 Ratios
- The Return On Assets of NNOX (-31.64%) is worse than 84.00% of its industry peers.
- NNOX has a worse Return On Equity (-35.55%) than 69.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -31.64% | ||
| ROE | -35.55% | ||
| ROIC | N/A |
ROA(3y)-32.63%
ROA(5y)-26.69%
ROE(3y)-37.21%
ROE(5y)-30.36%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for NNOX so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. NNOX Health Analysis
2.1 Basic Checks
- NNOX does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, NNOX has more shares outstanding
- NNOX has more shares outstanding than it did 5 years ago.
- The debt/assets ratio for NNOX has been reduced compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of 0.86, we must say that NNOX is in the distress zone and has some risk of bankruptcy.
- NNOX has a Altman-Z score of 0.86. This is in the lower half of the industry: NNOX underperforms 70.00% of its industry peers.
- NNOX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.86 |
ROIC/WACCN/A
WACC8.42%
2.3 Liquidity
- A Current Ratio of 4.14 indicates that NNOX has no problem at all paying its short term obligations.
- NNOX has a better Current ratio (4.14) than 90.00% of its industry peers.
- NNOX has a Quick Ratio of 3.93. This indicates that NNOX is financially healthy and has no problem in meeting its short term obligations.
- NNOX has a Quick ratio of 3.93. This is amongst the best in the industry. NNOX outperforms 90.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.14 | ||
| Quick Ratio | 3.93 |
3. NNOX Growth Analysis
3.1 Past
- The earnings per share for NNOX have decreased strongly by -14.29% in the last year.
- NNOX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.19%.
- Measured over the past years, NNOX shows a very strong growth in Revenue. The Revenue has been growing by 105.51% on average per year.
EPS 1Y (TTM)-14.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-40%
Revenue 1Y (TTM)15.19%
Revenue growth 3Y105.51%
Revenue growth 5YN/A
Sales Q2Q%13.72%
3.2 Future
- NNOX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.40% yearly.
- NNOX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 77.13% yearly.
EPS Next Y-4.8%
EPS Next 2Y16.99%
EPS Next 3Y17.54%
EPS Next 5Y25.4%
Revenue Next Year11.87%
Revenue Next 2Y63.07%
Revenue Next 3Y68.88%
Revenue Next 5Y77.13%
3.3 Evolution
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. NNOX Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for NNOX. In the last year negative earnings were reported.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NNOX. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as NNOX's earnings are expected to grow with 17.54% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.99%
EPS Next 3Y17.54%
5. NNOX Dividend Analysis
5.1 Amount
- NNOX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NNOX Fundamentals: All Metrics, Ratios and Statistics
2.27
-0.02 (-0.87%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-20 2025-11-20/bmo
Earnings (Next)04-06 2026-04-06/bmo
Inst Owners24.68%
Inst Owner Change26.66%
Ins Owners0.22%
Ins Owner Change0%
Market Cap157.11M
Revenue(TTM)12.30M
Net Income(TTM)-55.71M
Analysts84
Price Target7.55 (232.6%)
Short Float %13.86%
Short Ratio9.18
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-7.59%
Min EPS beat(2)-18.68%
Max EPS beat(2)3.49%
EPS beat(4)2
Avg EPS beat(4)-5.4%
Min EPS beat(4)-18.68%
Max EPS beat(4)3.49%
EPS beat(8)5
Avg EPS beat(8)8.63%
EPS beat(12)6
Avg EPS beat(12)-1.82%
EPS beat(16)7
Avg EPS beat(16)-8.44%
Revenue beat(2)0
Avg Revenue beat(2)-5.27%
Min Revenue beat(2)-7.01%
Max Revenue beat(2)-3.53%
Revenue beat(4)0
Avg Revenue beat(4)-15.94%
Min Revenue beat(4)-30.68%
Max Revenue beat(4)-3.53%
Revenue beat(8)0
Avg Revenue beat(8)-21.55%
Revenue beat(12)0
Avg Revenue beat(12)-21.38%
Revenue beat(16)1
Avg Revenue beat(16)-14.7%
PT rev (1m)-9.2%
PT rev (3m)-9.2%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 12.77 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1 | ||
| P/tB | 1.66 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.88
EYN/A
EPS(NY)-0.52
Fwd EYN/A
FCF(TTM)-0.65
FCFYN/A
OCF(TTM)-0.59
OCFYN/A
SpS0.18
BVpS2.26
TBVpS1.37
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -31.64% | ||
| ROE | -35.55% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-32.63%
ROA(5y)-26.69%
ROE(3y)-37.21%
ROE(5y)-30.36%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.07
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 36.96% | ||
| Cap/Sales | 35.41% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 4.14 | ||
| Quick Ratio | 3.93 | ||
| Altman-Z | 0.86 |
F-Score3
WACC8.42%
ROIC/WACCN/A
Cap/Depr(3y)37.93%
Cap/Depr(5y)1552.65%
Cap/Sales(3y)47.15%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-40%
EPS Next Y-4.8%
EPS Next 2Y16.99%
EPS Next 3Y17.54%
EPS Next 5Y25.4%
Revenue 1Y (TTM)15.19%
Revenue growth 3Y105.51%
Revenue growth 5YN/A
Sales Q2Q%13.72%
Revenue Next Year11.87%
Revenue Next 2Y63.07%
Revenue Next 3Y68.88%
Revenue Next 5Y77.13%
EBIT growth 1Y-6.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y5.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y9.37%
OCF growth 3YN/A
OCF growth 5YN/A
NANO-X IMAGING LTD / NNOX Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for NANO-X IMAGING LTD?
ChartMill assigns a fundamental rating of 3 / 10 to NNOX.
What is the valuation status for NNOX stock?
ChartMill assigns a valuation rating of 0 / 10 to NANO-X IMAGING LTD (NNOX). This can be considered as Overvalued.
How profitable is NANO-X IMAGING LTD (NNOX) stock?
NANO-X IMAGING LTD (NNOX) has a profitability rating of 0 / 10.
What is the earnings growth outlook for NANO-X IMAGING LTD?
The Earnings per Share (EPS) of NANO-X IMAGING LTD (NNOX) is expected to decline by -4.8% in the next year.